SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-02-004679
Filing Date
2002-10-28
Accepted
2002-10-28 16:08:30
Documents
7
Period of Report
2002-10-22
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 INTERLEUKIN GENETICS, INC. b44639lge8vk.txt 8-K 8777
3 NOTE PURCHASE AGREEMENT b44639lgexv10w1.txt EX-10.1 53259
4 SECURITY AGREEMENT b44639lgexv10w2.txt EX-10.2 16882
5 FORM OF PROMISSORY NOTE b44639lgexv10w3.txt EX-10.3 10777
6 AGREEMENT AND WAIVER b44639lgexv10w4.txt EX-10.4 13075
7 AGREEMENT AND WAIVER b44639lgexv10w5.txt EX-10.5 12353
8 PRESS RELEASE DATED 24-OCTOBER-2002 b44639lgexv99w1.txt EX-99.1 4439
  Complete submission text file 0000950135-02-004679.txt   122018
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23413 | Film No.: 02800046
SIC: 2835 In Vitro & In Vivo Diagnostic Substances